Next Article in Journal
Evidence of SARS-CoV-2 Virus in the Middle Ear of Deceased COVID-19 Patients
Next Article in Special Issue
Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
Previous Article in Journal
Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis
Previous Article in Special Issue
Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation
 
 
Review
Peer-Review Record

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications

Diagnostics 2021, 11(9), 1534; https://doi.org/10.3390/diagnostics11091534
by Aleksander Salomon-Perzyński 1, Krzysztof Jamroziak 2 and Eliza Głodkowska-Mrówka 3,4,5,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Diagnostics 2021, 11(9), 1534; https://doi.org/10.3390/diagnostics11091534
Submission received: 29 July 2021 / Revised: 17 August 2021 / Accepted: 19 August 2021 / Published: 25 August 2021
(This article belongs to the Special Issue Hematological Neoplasms)

Round 1

Reviewer 1 Report

The manuscript presented by the authors has reviewed the recent advances of clonal evolution patterns in MM from different aspects, and also discussed the clinical implications from genomic aberrations. The paper was well organized and included the most updated data and findings related. They were well displayed and informative. I have nothing to add in.

 

Author Response

The authors are thankful for the kind comments from the reviewer. In the reviewing process, slight corrections to the introduction section have been made. Otherwise, the manuscript has not been changed.

Reviewer 2 Report

Very well-written and comprehensive review on the Subject, presenting the different modes of evolution and spatiotemporal dynamics particularly well. I would propose a few minor changes.

  1. An extra paragraph in the introduction presenting the new horizons clearly opened be the rapid advancements in NGS technologies. 
  2. A bit more extensive mention of single-cell NGS, particularly scRNAseq, which have achieved breakthrough fundamental discoveries regarding new potential therapeutic directions (for instance: Cohen, Y.C., Zada, M., Wang, SY. et al., Nat Med 27, 491–503, 2021).

Author Response

Dear Reviewer,

Please find below the responses to your comments.

Comment #1

An entirely new paragraph on the advances in NGS technologies has been added to the Introduction section. In addition, some minor editing has been applied to this section as well to make it more readable (lines 31-66).

Comment #2

As suggested, a new paragraph on the advances in single-cell sequencing techniques and their input into our understanding of myeloma biology has been added (lines 498-508) together with 2 references (ref#95 and ref#96).

 

Back to TopTop